Uploaded September 2025 | Updated September 2026, 1 week ago

---

Dr. Bob Hendren, member of ARI's Board of Directors and Scientific Advisory Board, discusses the critical role of private funding as the starting point for impactful, cutting-edge research.

Dr. Robert L. Hendren, specializes in the diagnosis and treatment of neurodevelopmental disorders such as pervasive developmental, bipolar, schizophrenia spectrum and impulse control disorders. In his research, he studies pharmacology and nutrition in treating autism, and the biological effects of nutritional supplementation including vitamin B12, vitamin D, Omega-3 fatty acids. Learn more about Dr. Hendren at https://profiles.ucsf.edu/robert.hendren